Skip to main content
Caplight Logo









Cyclic Therapeutics AB

Cyclic Therapeutics AB

Private
StockholmHealthcare & Life Scienceshttps://cyclictx.com/

Company Overview

Cyclic Therapeutics AB operates in Healthcare & Life Sciences and is based in Stockholm. It was founded in 2024.

Cyclic Therapeutics AB is a biotech company that develops next-generation peptide therapeutics using an AI-driven, sequence-only design platform.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Cyclic Therapeutics AB Comparables

Compare Cyclic Therapeutics AB with similar companies based on industry and business-model similarity.

Cyclic Therapeutics AB comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Meddenovo Drug Design
88%
Insamo
82%
Menten AI
81%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Cyclic Therapeutics AB Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for Cyclic Therapeutics AB. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 11, 2026

    Monthly visitors increased 55% MoM, reaching 5.1K.

Book a demo to see all signals

For institutional investors. Book with your work email.

Cyclic Therapeutics AB Filings

Explore SEC and related filing metadata, where available.

Cyclic Therapeutics AB filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Cyclic Therapeutics AB's valuation, stock price, and market status.

Is Cyclic Therapeutics AB a public or private company?

Cyclic Therapeutics AB is a private company.

What is the current stock price of Cyclic Therapeutics AB?

Cyclic Therapeutics AB is a private company, so its shares have no public market price. Caplight tracks Cyclic Therapeutics AB's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Cyclic Therapeutics AB worth (valuation)?

Valuation information for Cyclic Therapeutics AB is not publicly available.

Can I buy Cyclic Therapeutics AB stock?

Cyclic Therapeutics AB shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Cyclic Therapeutics AB's last funding round?

Funding round information for Cyclic Therapeutics AB is not publicly available.

Who are the main investors in Cyclic Therapeutics AB?

Investor information for Cyclic Therapeutics AB is not publicly disclosed.

Will Cyclic Therapeutics AB IPO soon?

No public IPO plans have been announced for Cyclic Therapeutics AB.

How can I track Cyclic Therapeutics AB secondary market activity?

Caplight tracks bids, offers, and trades in Cyclic Therapeutics AB's shares on secondary markets.

Firmographic Details

HeadquartersStockholm
Employee Range1
Year Founded2024
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?